Organon Reports Results for the Third Quarter Ended September 30, 2021
Go back to Organon Reports Results for the Third Quarter Ended September 30, 2021| Merck & Co. (NYSE: MRK) | Delayed: 149.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $149.50 | 52 Week High | $65.46 | |||
| Open | $149.50 | 52 Week Low | $47.97 | |||
| Day High | $149.50 | P/E | 101.70 | |||
| Day Low | $149.50 | EPS | $1.47 | |||
| Volume | 11,786 | |||||
| (NYSE: OGN) | Delayed: 13.68 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.68 | 52 Week High | $8.00 | |||
| Open | $13.68 | 52 Week Low | $8.00 | |||
| Day High | $13.68 | P/E | N/A | |||
| Day Low | $13.68 | EPS | $0.00 | |||
| Volume | 2 | |||||
